Gubra AS (STU:PI3) Cash Receipts from Tax Refunds


STU:PI3 Gubra AS STU:PI3
58 GF Score
Price €44.22
GF Value €381.21
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Gubra AS Cash Receipts from Tax Refunds?

Cash Receipts from Tax Refunds only applicable to companies reporting Cash Flow from Operations in direct method.

STU:PI3
58GF Score
Gubra AS STU:PI3
Cash Receipts from Tax Refunds is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Gubra AS (STU:PI3) Overvalued in 2026?

Based on GuruFocus' analysis, Gubra AS stock appears to be undervalued. The current stock price of €44.22 is trading 88.4% below its estimated GF Value™ of €381.21. GuruFocus considers Gubra AS to be Possible Value Trap.

Key valuation signals for STU:PI3:

  • Cash Receipts from Tax Refunds:
  • GF Value™: €381.21 vs. price of €44.22 (88.4% below fair value)
  • GF Score™: 58/100 with 3 warning signs

No single metric tells the full story. See the STU:PI3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Gubra AS Business Description

Other Exchanges GUBRA:Denmark
Address Horsholm Kongevej 11B, Horsholm, DNK, 2970
Gubra AS is a specialized preclinical CRO and biotech company focused on peptide-based drug discovery within metabolic and fibrotic diseases. The company has two segments: Pre-clinical contract research (CRO), which derives maximum revenue and Biotech Segment. It derives maximum revenue from Pre-clinical contract research (CRO) segment. Geographically, the company operates in Europe, North America and Other regions.
58GF Score

Get the complete analysis for STU:PI3

Cash Receipts from Tax Refunds is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€44.22
Price
€381.21
GF Value